Ignite Creation Date:
2024-05-06 @ 3:22 PM
Last Modification Date:
2024-10-26 @ 1:48 PM
Study NCT ID:
NCT04609319
Status:
COMPLETED
Last Update Posted:
2024-04-30
First Post:
2020-10-23
Brief Title:
Real World Utilization and Outcomes With Dacomitinib First Line Treatment for EGFR Mutation-positive Advanced Non Small Cell Lung Cancer Among Asian Patients - A Multi Center Chart Review
Sponsor:
Pfizer
Organization:
Pfizer
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-01-23
Start Date Type:
ACTUAL
Primary Completion Date:
2024-06-04
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-10-08
Completion Date Type:
ESTIMATED
First Submit Date:
2020-10-23
First Submit QC Date:
October 23 2020
Study First Post Date:
2020-10-30
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-07-15
Last Update Post Date:
2024-04-30
Last Update Post Date Type:
ACTUAL